Cargando…
Opportunities and Barriers of Telemedicine in Rheumatology: A Participatory, Mixed-Methods Study
Despite all its promises, telemedicine is still not widely implemented in the care of rheumatic and musculoskeletal diseases (RMDs). The aim of this study is to investigate opportunities, barriers, acceptance, and preferences concerning telemedicine among RMD patients and professional stakeholders....
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701397/ https://www.ncbi.nlm.nih.gov/pubmed/34948737 http://dx.doi.org/10.3390/ijerph182413127 |
_version_ | 1784620990531108864 |
---|---|
author | Muehlensiepen, Felix Knitza, Johannes Marquardt, Wenke May, Susann Krusche, Martin Hueber, Axel Schwarz, Julian Vuillerme, Nicolas Heinze, Martin Welcker, Martin |
author_facet | Muehlensiepen, Felix Knitza, Johannes Marquardt, Wenke May, Susann Krusche, Martin Hueber, Axel Schwarz, Julian Vuillerme, Nicolas Heinze, Martin Welcker, Martin |
author_sort | Muehlensiepen, Felix |
collection | PubMed |
description | Despite all its promises, telemedicine is still not widely implemented in the care of rheumatic and musculoskeletal diseases (RMDs). The aim of this study is to investigate opportunities, barriers, acceptance, and preferences concerning telemedicine among RMD patients and professional stakeholders. From November 2017 to December 2019, a participatory, mixed-methods study was conducted, consisting of (1) expert interviews (n = 27) with RMD patients and professional stakeholders, (2) a national paper-based patient survey (n = 766), and (3) focus groups (n = 2) with patient representatives and rheumatologists. The qualitative findings indicate that patients equate personal contact with physical face-to-face contact, which could be reduced by implementing telemedicine, thus negatively influencing the patient–doctor relationship. Correspondingly “no personal contact with the doctor” is the main reason (64%) why 38% of the surveyed patients refuse to try telemedicine. Professional stakeholders expect telemedicine to contribute to the effective allocation of scarce resources in rheumatology care. The main barriers reported by stakeholders were the scarcity of time resources in RMD care, the absence of physical examinations, and organizational challenges associated with the implementation of telemedicine in RMD care. While the exact integration of telemedicine into routine care has yet to be found, the consequences on the patient-physician relationship must be permanently considered. |
format | Online Article Text |
id | pubmed-8701397 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87013972021-12-24 Opportunities and Barriers of Telemedicine in Rheumatology: A Participatory, Mixed-Methods Study Muehlensiepen, Felix Knitza, Johannes Marquardt, Wenke May, Susann Krusche, Martin Hueber, Axel Schwarz, Julian Vuillerme, Nicolas Heinze, Martin Welcker, Martin Int J Environ Res Public Health Article Despite all its promises, telemedicine is still not widely implemented in the care of rheumatic and musculoskeletal diseases (RMDs). The aim of this study is to investigate opportunities, barriers, acceptance, and preferences concerning telemedicine among RMD patients and professional stakeholders. From November 2017 to December 2019, a participatory, mixed-methods study was conducted, consisting of (1) expert interviews (n = 27) with RMD patients and professional stakeholders, (2) a national paper-based patient survey (n = 766), and (3) focus groups (n = 2) with patient representatives and rheumatologists. The qualitative findings indicate that patients equate personal contact with physical face-to-face contact, which could be reduced by implementing telemedicine, thus negatively influencing the patient–doctor relationship. Correspondingly “no personal contact with the doctor” is the main reason (64%) why 38% of the surveyed patients refuse to try telemedicine. Professional stakeholders expect telemedicine to contribute to the effective allocation of scarce resources in rheumatology care. The main barriers reported by stakeholders were the scarcity of time resources in RMD care, the absence of physical examinations, and organizational challenges associated with the implementation of telemedicine in RMD care. While the exact integration of telemedicine into routine care has yet to be found, the consequences on the patient-physician relationship must be permanently considered. MDPI 2021-12-13 /pmc/articles/PMC8701397/ /pubmed/34948737 http://dx.doi.org/10.3390/ijerph182413127 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Muehlensiepen, Felix Knitza, Johannes Marquardt, Wenke May, Susann Krusche, Martin Hueber, Axel Schwarz, Julian Vuillerme, Nicolas Heinze, Martin Welcker, Martin Opportunities and Barriers of Telemedicine in Rheumatology: A Participatory, Mixed-Methods Study |
title | Opportunities and Barriers of Telemedicine in Rheumatology: A Participatory, Mixed-Methods Study |
title_full | Opportunities and Barriers of Telemedicine in Rheumatology: A Participatory, Mixed-Methods Study |
title_fullStr | Opportunities and Barriers of Telemedicine in Rheumatology: A Participatory, Mixed-Methods Study |
title_full_unstemmed | Opportunities and Barriers of Telemedicine in Rheumatology: A Participatory, Mixed-Methods Study |
title_short | Opportunities and Barriers of Telemedicine in Rheumatology: A Participatory, Mixed-Methods Study |
title_sort | opportunities and barriers of telemedicine in rheumatology: a participatory, mixed-methods study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701397/ https://www.ncbi.nlm.nih.gov/pubmed/34948737 http://dx.doi.org/10.3390/ijerph182413127 |
work_keys_str_mv | AT muehlensiepenfelix opportunitiesandbarriersoftelemedicineinrheumatologyaparticipatorymixedmethodsstudy AT knitzajohannes opportunitiesandbarriersoftelemedicineinrheumatologyaparticipatorymixedmethodsstudy AT marquardtwenke opportunitiesandbarriersoftelemedicineinrheumatologyaparticipatorymixedmethodsstudy AT maysusann opportunitiesandbarriersoftelemedicineinrheumatologyaparticipatorymixedmethodsstudy AT kruschemartin opportunitiesandbarriersoftelemedicineinrheumatologyaparticipatorymixedmethodsstudy AT hueberaxel opportunitiesandbarriersoftelemedicineinrheumatologyaparticipatorymixedmethodsstudy AT schwarzjulian opportunitiesandbarriersoftelemedicineinrheumatologyaparticipatorymixedmethodsstudy AT vuillermenicolas opportunitiesandbarriersoftelemedicineinrheumatologyaparticipatorymixedmethodsstudy AT heinzemartin opportunitiesandbarriersoftelemedicineinrheumatologyaparticipatorymixedmethodsstudy AT welckermartin opportunitiesandbarriersoftelemedicineinrheumatologyaparticipatorymixedmethodsstudy |